ZEJULA (niraparib) 100 mcg Capsule

How it Works: Niraparib works by inhibiting the activity of PARP enzymes, which are involved in repairing damaged DNA in cells. By blocking PARP, niraparib prevents cancer cells from repairing damaged DNA, ultimately leading to their death. This helps in slowing down or stopping the growth of cancer cells. Side Effects: Nausea Fatigue Anemia (low red blood cell count) Thrombocytopenia (low platelet count) Neutropenia (low white blood cell count) Indications: ZEJULA is indicated for: Maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy. Contraindications: ZEJULA should not be used in individuals who: Have a known hypersensitivity to niraparib or any of the ingredients in ZEJULA. Are pregnant, as it can cause harm to the unborn baby. Price Comparison:

Country	Price	Reference
Pakistan	PKR 153,080	medicalstore.com.pk
United States	USD 12,567	GoodRx
United Kingdom	GBP 8,500	Boots UK
Canada	CAD 10,200	Costco Canada
Australia	AUD 9,800	Chemist Warehouse AU

Top 5 Global Brands:

ZEJULA (Niraparib) Lynparza (Olaparib) Rubraca (Rucaparib) Talzenna (Talazoparib) Veliparib